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Major histocompatibility complex (MHC) class I
molecules assemble with peptides in the ER lu-
men and are transported via Golgi to the plasma
membrane for recognition by T cells. Inhibiting
MHC assembly, transport, and surface expres-
sion are common viral strategies of evading
immune recognition. Cowpox virus, a clinically
relevant orthopoxvirus, downregulates MHC
class I expression on infected cells. However,
the viral protein(s) andmechanisms responsible
are unknown.We identifyCPXV203asa cowpox
virus protein that associates with fully assem-
bled MHC class I molecules and blocks their
transport through the Golgi. A C-terminal KTEL
motif in CPXV203 closely resembles the canon-
ical ER retention motif KDEL and is required for
CPXV203 function, indicating that a physiologic
pathway is exploited to retainMHC class I in the
ER. This viral mechanism for MHC class I down-
regulation may explain virulence differences
between clinical isolates of orthopoxviruses.
INTRODUCTION
Orthopoxviruses are clinically important infectious agents.
Variola virus (VARV) causes smallpox, one of the most
devastating human diseases. Naturally occurring small-
poxwas eradicated in the late 20th century by aworldwide
vaccination program using vaccinia virus (VACV) (Fenner
et al., 1988). However, the potential threat of deliberate
reintroduction of VARV still exists (Smith and McFadden,
2002). Other orthopoxviruses, such as cowpox virus
(CPXV) and monkeypox virus (MPXV) cause human
disease through zoonosis (Lewis-Jones, 2004). CPXV is
endemic in Europe, where occasional transmission to
humans often occurs via contact with infected domestic
cats (Chantrey et al., 1999; Lewis-Jones, 2004). MPXV
causes a smallpox-like disease in humans (Breman
et al., 1980; Jezek et al., 1987). Since the first case report
in 1970, sporadic outbreaks of human monkeypox have306 Cell Host & Microbe 2, 306–315, November 2007 ª2007 Eloccurred in Central and West Africa and recently in the
United States, with Central African clades demonstrating
more virulence (Breman et al., 1980; Foster et al., 1972;
Ladnyj et al., 1972; Reed et al., 2004). The basis for differ-
ence in virulence between MPXV clades is largely un-
known and under active investigation (Chen et al., 2005;
Likos et al., 2005). However, it is likely that viral immune
evasion strategies contribute to differences in virulence.
In their large DNA genomes, poxviruses encode some
of the most extensive inventories of genes dedicated to
evading the host immune system. Targets of these genes
are comprehensive, including primary mediators of both
innate and adaptive immunity such as complement sys-
tem, interferons, inflammatory cytokines, and chemokines
(Seet et al., 2003). Among the orthopoxviruses, CPXV en-
codes the most complete repertoire of immunomodula-
tory genes, and comparative analysis of orthopoxvirus
genomes suggested that CPXV or CPXV-like virus was
the ancestor of all the modern orthopoxviruses (Meyer
et al., 2002; Shchelkunov et al., 2002). Therefore, CPXV
is ideal to study orthopoxvirus-encoded immune evasion
mechanisms.
The important role of cytotoxic T lymphocytes (CTL) in
controlling virus infection is highlighted by viral evasion
strategies. CTLs usually recognize antigens processed
by the major histocompatibility complex (MHC) class I an-
tigen presentation pathway (Townsend et al., 1989). MHC
class I molecules, composed of heavy chain and b2-mi-
croglobulin (b2m), fold and assemble in the lumen of the
endoplasmic reticulum (ER) with the help of chaperones
(Pamer and Cresswell, 1998). Peptides generated by the
proteasomes in the cytosol are translocated into the ER
lumen by the transporter associatedwith antigen process-
ing (TAP). Upon peptide loading with the aid of the loading
complex including TAP, tapasin, ERp57, and calreticulin,
MHC class I molecules leave the ER and travel to the
plasma membrane through the secretory pathway. On
the cell surface, they present peptides sampled from the
endogenous protein repertoire including virus-derived
peptides. Upon recognition of viral peptide-MHC class I
complex through the T cell receptor, virus-specific CTLs
kill the infected cells and produce inflammatory cytokines
such as interferon-g and tumor necrosis factor-a to pre-
vent further viral spread (Guidotti and Chisari, 1996). Tosevier Inc.
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MHC Class I Downregulation by Cowpox VirusFigure 1. Selective Downregulation of
MHC Class I Molecules on CPXV-
Infected Cells
MC57G fibroblast cells (A) and macrophages
derived from BALB/c bone marrow (B) were
either mock infected (dashed line) or infected
with CPXV at a multiplicity of infection (MOI)
of 5 (solid line). At 24 hr postinfection,
MC57G cells were stained with antibodies to
Kb, Db, and transferrin receptor (TfR), andmac-
rophages were stained with antibodies to Kd,
Dd, and CD11b. Stained cells were analyzed
by flow cytometry. Gray-filled histograms
represent isotype-control antibody staining.avoid the antiviral action of CTLs, many viruses, notably
the large DNA viruses, have evolved evasion mechanisms
targeting the MHC class I antigen presentation pathway
(Tortorella et al., 2000).
While the downregulation of MHC class I molecules on
the cell surface protects virus-infected cells from recogni-
tion and killing by CD8 T cells, it leaves the infected cells
susceptible to lysis by natural killer (NK) cells owing to
the reduced engagement of MHC class I molecules by
NK cell inhibitory receptors. The recent discovery of ortho-
poxvirus MHC class I-like protein (OMCP) that acts as
a competitive antagonist of an NK cell activating receptor
NKG2D (Campbell et al., 2007) explains how orthopoxvi-
ruses can counteract NK cell attack and predicts that or-
thopoxviruses may downregulate MHC class I. However,
until recently, there was no report that orthopoxviruses
specifically modulate MHC class I expression.
Recently, CPXV was reported to evade recognition by
CPXV-specific CD8+ T cells (Dasgupta et al., 2007). In
this study, the authors demonstrated that CPXV induces
downregulation of human MHC class I molecules from
the cell surface by inhibiting the intracellular transport of
peptide-loaded MHC class I (Dasgupta et al., 2007).
However, the molecular basis of this evasion mechanism
is largely unknown because the CPXV protein responsible
for the modulation of MHC class I expression was not
identified.
Herewe used a comparative genomics-based approach
and a gain-of-function screening to identify CPXV gene(s)
capable of MHC class I downregulation. Interestingly, we
found that CPXV encodes more than one gene that can
modulate MHC class I expression. We report the identifi-
cation and characterization of CPXV203 protein, which is
sufficient for the downregulation of mouse and human
MHC class I molecules. Mechanistically, CPXV203 uses
the physiologic KDEL pathway to specifically retain MHC
class I molecules in the ER.Cell Host &RESULTS
Downregulation of MHC Class I on the Surface
of CPXV-Infected Cells
Despite its name, the natural reservoir hosts of CPXV are
wild rodents (Chantrey et al., 1999). To study CPXV-medi-
ated MHC class I downregulation in a relevant murine
host system, we infected various murine cell types with
CPXV. MC57G fibroblast cells infected with CPXV strain
Brighton Red (BR) displayed dramatically reduced surface
expression of both Kb and Db at 24 hr postinfection com-
pared to the mock-infected cells (Figure 1A). We also
observed downregulation of Kb and Db on C57BL/6-
derived bone marrow-derived macrophages (BMMs) and
dendritic cells infected with CPXV (Figure S1A in the Sup-
plemental Data available with this article online). Further-
more, the expression levels of Kd and Dd on the BALB/c-
derived BMMs (Figure 1B) and Kk and Dk in L929 fibroblast
cells (Figure S1A) were also reduced upon CPXV infection.
Interestingly, cell surface expression of transferrin recep-
tor (Figure 1A), CD11b (Figure 1B), CD11c, and CD44
(Figure S1A) remained unaffected at 24 hr postinfection,
suggesting that downregulation was specific to MHC
class I molecules. In summary, CPXV induces downregu-
lation of broad range of murine MHC class I molecules
from various cell types.
We also examined the time course of MHC class I
downregulation in MC57G cells. Similar to what was
reported for human MHC class I molecules (Dasgupta
et al., 2007), the decrease of surface Kb expression was
detectable at 4 hr postinfection and progressed further
until 24 hr postinfection (data not shown). Furthermore,
blocking viral intermediate and late gene transcription by
AraC treatment did not abolish MHC class I downregula-
tion (Figure S1B). Together, these data indicated that an
early gene product(s) of CPXV is responsible for the
phenotype.Microbe 2, 306–315, November 2007 ª2007 Elsevier Inc. 307
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MHC Class I Downregulation by Cowpox VirusFigure 2. Impaired Intracellular Transport of MHC Class I in CPXV-Infected Cells
(A) MC57G cells were either mock infected (dashed line) or infected with CPXV at a MOI of 5 (solid line). At 24 hr postinfection, cells were fixed,
permeabilized, and stained with antibodies to Kb or transferrin receptor (TfR). Stained cells were analyzed by flow cytometry. Gray-filled histograms
represent isotype-control antibody staining.
(B) MC57G cells were either mock infected or infected with CPXV at a MOI of 5. At 6 hr postinfection, cells were pulse labeled for 10min with [35S]cys-
teine/methionine and chased for the indicated time periods. Db heavy chain (HC) and transferrin receptor (TfR) were immunoprecipitated from the cell
lysates and either Endo H-treated or mock treated prior to SDS-PAGE. A representative result of three independent experiments is shown.Impaired Intracellular Trafficking of MHC Class I
Molecules in CPXV-Infected Cells
To elucidate the mechanism by which CPXV interferes
with MHC class I expression, we examined whether the
decrease of surface expression simply reflected a reduc-
tion of total cellular MHC class I level. Surprisingly, in
contrast to the severely reduced surface expression, we
detected increased amounts of Kb in CPXV-infected
MC57G cells than in the mock-infected cells by intracellu-
lar staining (Figure 2A). The total level of transferrin recep-
tor remained unchanged, indicating that the increase of
total Kb expressionwas not due to a cytopathic effect (Fig-
ure 2A). These data argued against an accelerated degra-
dation of MHC class I molecules as the mechanism for
downregulation of their surface level.
We then investigated a potential defect in the intracellu-
lar transport of MHC class I molecules by examining En-
doglycosidase H (Endo H) sensitivity of newly synthesized
MHC class I heavy chains. In the mock-infected MC57G
cells, most Db heavy chains acquired Endo H resistance
within the 240 min chase period, consistent with glycosyl-
ation during transit through the Golgi complex. However,
during the same time period, Db heavy chains in CPXV-
infected cells remained Endo H sensitive, indicating a
block in the trafficking to themedial Golgi (Figure 2B). Sim-
ilarly, newly synthesized Kb heavy chains remained Endo
H sensitive in CPXV-infected cells (data not shown). These
results were not due to a general impairment of protein308 Cell Host & Microbe 2, 306–315, November 2007 ª2007 Elsetrafficking because trafficking of transferrin receptors
remained unaffected in CPXV-infected cells (Figure 2B).
Taken together, these data indicated that CPXV induces
selective retention of MHC class I molecules in the pre-
Golgi compartments, causing MHC class I downregula-
tion at the cell surface.
Identification of CPXV203 as a CPXV-Encoded
MHC Class I Modulator
To further investigate the molecular basis for this poten-
tial immune evasion mechanism, we searched for a
CPXV gene product(s) capable of modulating MHC class
I expression. Preliminary experiments demonstrated that
other closely related orthopoxviruses, VACV strain West-
ern Reserve (WR) and ectromelia virus (ECTV) strain
Moscow, do not induce selective MHC class I downregu-
lation (data not shown), indicating that only CPXV, but
not VACV or ECTV, encodes protein(s) mediating this
potential immune evasion. We used the Poxvirus Bioin-
formatics Resource Center (PBRC) database to compare
the genome of CPXV BR to those of VACV WR and ECTV
Moscow. Candidate open reading frames (ORFs) were
selected if (1) they are present in CPXV but not in the
other viruses, or (2) they encode proteins with less than
80% amino acid identity to the VACV or ECTV orthologs.
These candidate genes were cloned from genomic DNA
and expressed individually in BaF/3 cells using a retroviral
expression system.vier Inc.
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MHC Class I Downregulation by Cowpox VirusAmong the 21 genes tested, the expression ofCPXV203
induced downregulation of Kd from the surface of BaF/3
cells (Figure S2A). To confirm this result, CPXV203 was
expressed in anothermurine cell line, C1498, using a bicis-
tronic retroviral expression vector encoding enhanced
green fluorescent protein (GFP) for ready detection of
transduced cells. C1498 cells transduced with CPXV203
had dramatically reduced levels of Kb and Db on the cell
surface in comparison with the nontransduced cells or
cells transduced with the vector alone (Figure 3A). The ex-
pression levels of other surface proteins were unaffected
by CPXV203 transduction (data not shown). Furthermore,
transduction of CPXV203 in the human cell line Jurkat
induced downregulation of human MHC class I molecules
on the cell surface (Figure 3B). Similar results were
obtained using another human cell line 293T (data not
shown). Thus, the gene product of CPXV203 can modu-
late both murine and human MHC class I expression.
To understand the mechanism by which CPXV203
modulates surface MHC class I expression, we examined
the total amount of MHC class I in CPXV203-transduced
cells by intracellular staining. As seen with CPXV-infected
Figure 3. Downregulation of Murine and Human MHC Class I
by CPXV203
C1498 cells (A) and Jurkat cells (B) that were transduced with either
control retroviral vector alone or CPXV203 were stained with anti-
bodies to Kb, Db, or HLA-ABC and analyzed by flow cytometry. The
retroviral vectors used for transduction encode GFP, and thus only
successfully transduced cells are GFP positive. The numbers in the
gates indicate mean fluorescence intensity of MHC class I molecules
for GFP-negative and -positive populations.Cell Host &cells, total levels of Kb andDbwere increased inCPXV203-
transduced cells compared to the cells transduced with
vector alone (Figure 4A). Moreover, trafficking of Kb (Fig-
ure S2B) and Db (Figure 4B) through the Golgi complex
was impaired in CPXV203-transduced cells. Therefore,
CPXV203 induces accumulation and retention of MHC
class I molecules in the pre-Golgi compartments, confer-
ring the phenotype of CPXV-infected cells.
ER Localization of CPXV203 and the Physical
Association with MHC Class I
To understand how CPXV203 achieves intracellular
retention of MHC class I, we examined the subcellular lo-
calization of CPXV203 protein by immunofluorescence
microscopy. CPXV203 with the insertion of HA epitope
between the residue G107 and A108 (CPXV203-HA) was
still capable of downregulating MHC class I molecules
(data not shown). Staining of CPXV203-HA in B6/WT-3
cells with HA-specific antibody revealed a reticular pattern
colocalized with that of calnexin, an ER-resident protein
(Figure 5A). Furthermore, CPXV203-HA did not colocalize
with the Golgi marker giantin (Figure 5A). These data
indicated that CPXV203 protein resides in the ER.
Figure 4. Inhibition of MHC Class I Trafficking by CPXV203
(A) C1498 cells transduced with either vector alone (dashed line) or
CPXV203 (solid line) were subjected to intracellular staining with anti-
bodies to Kb and Db. Gray-filled histograms represent isotype-control
antibody staining.
(B) The same set of cells in (A) wasmetabolically labeled for 10min and
chased for the indicated periods of time. Db was immunoprecipitated
from the cell lysates and treated with Endo H where indicated. Precip-
itated proteins were separated by SDS-PAGE and visualized by auto-
radiography. A representative result of three independent experiments
is shown.Microbe 2, 306–315, November 2007 ª2007 Elsevier Inc. 309
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MHC Class I Downregulation by Cowpox VirusFigure 5. Physical Association between CPXV203 and MHC Class I Molecules
(A) B6/WT-3 cells were transduced with CPXV203-HA and stained with antibodies to HA, an ERmarker calnexin, or a Golgi marker giantin. Nontrans-
duced cells that express calnexin but not CPXV203-HA are indicated by arrows.
(B) C1498 cells transduced with CPXV203-HA were lysed with 1% digitonin. Whole lysate (WL) and immunoprecipitates of anti-HA antibody (IP-HA)
or isotype-control antibody (IP-ctrl) were separated by SDS-PAGE and examined by western blot analysis for the presence of Kb, b2m, TAP, and HA.
A representative result of more than three independent experiments is shown.Based on the ER localization of CPXV203, we hypothe-
sized two potential mechanisms by which CPXV203
retains MHC class I molecules in the ER. First, CPXV203
might interfere with the peptide loading of MHC class I
molecules, thereby their egress from the ER. However, in-
cubation with saturating concentration of Kb-binding pep-
tide VNVDYSKL (Sasada et al., 2001) did not restore the
reduced surface Kb expression on CPXV203-transduced
cells (Figure S3). Furthermore, we observed increased
amounts of peptide-loaded Kb and Db in CPXV203-trans-
duced C1498 cells, as detected by immunoprecipitation
with conformation-specific antibodies (B8-24-3 for pep-
tide-associated Kb and B22-249 for peptide-associated
Db) (data not shown). These data suggested that a defect
in peptide loading is unlikely to account for the ER reten-
tion of MHC class I by CPXV203.
The accumulation of peptide-loaded MHC class I mole-
cules in the presence of CPXV203 suggested, alterna-
tively, that CPXV203 might physically associate with
peptide-loaded MHC class I molecules, thereby holding
them in the ER. To test this hypothesis, we performed
coimmunoprecipitation experiments in C1498 cells ex-
pressing CPXV203-HA. We found Kb heavy chain and
b2m (Figure 5B) coprecipitated with the anti-HA antibody
but not with the isotype-control antibody. TAP, one of the
components of the peptide-loading complex, was not
detected in the anti-HA precipitates (Figure 5B). Taken
together, these data indicated that CPXV203 physically
associates with fully assembled MHC class I molecules,
after the latter dissociate from the peptide-loading com-
plex upon peptide acquisition.
Essential Role of KTEL in the Localization
and Function of CPXV203
The deduced CPXV203 protein contains a putative N-
terminal signal peptide and no predicted transmembrane310 Cell Host & Microbe 2, 306–315, November 2007 ª2007 Eldomain. The final four C-terminal residues (KTEL) closely
resemble the canonical ER retentionmotif KDEL. In animal
cells, soluble proteins bearing KDEL motif at their C ter-
mini are constantly retrieved upon escape from the ER
by the KDEL receptor, which recycles between the cis-
Golgi and the ER (Pelham, 1996). Variants of the KDEL
motif, including KTEL, with a similar function have been
described (Andres et al., 1990, 1991; Vennema et al.,
1992). Thus, the presence of KTEL sequence at the C ter-
minus of CPXV203 was consistent with the ER localization
of the protein.
We hypothesized that, if CPXV203 retainsMHCclass I in
the ER via the KTEL motif, deletion of this motif from
CPXV203 would lead to the release of the CPXV203/
MHC class I complex from the ER. Indeed, KTEL-deleted
CPXV203 did not downregulate MHC class I molecules
(Figure 6A). To test whether the functional defect of
KTEL-deleted CPXV203 was due to an inefficient ER
retention of CPXV203, we examined the fate of newly
synthesized full-length or KTEL-deleted CPXV203-HA
by metabolic labeling. As we predicted, KTEL-deleted
CPXV203-HA was rapidly secreted into the supernatant,
while the full-length form remained mostly intracellular
(Figures 6B and 6C). In conclusion, the KTEL motif of
CPXV203 is essential for the functional effect of CPXV203
on MHC class I.
Partial Rescue of MHC Class I Downregulation
by the Deletion of CPXV203
To study the role of CPXV203 in CPXV-mediated MHC
class I downregulation, we generated a recombinant virus
lacking CPXV203 (CPXVD203) by replacing the CPXV203
coding region with VACV I1L promoter-driven GFP, which
was flanked by two loxP sites for ready deletion of theGFP
cassette (Figure 7A). Deletion of CPXV203 was confirmed
by PCR, sequencing, and immunoblotting (Figure 7B).sevier Inc.
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MHC Class I Downregulation by Cowpox VirusFigure 6. Crucial Role of C-Terminal KTEL Motif in the Function of CPXV203
(A) Surface expression levels of Kb and Db on C1498 cells transduced with either full-length (FL) or KTEL-deleted (DKTEL) CPXV203 were analyzed by
flow cytometry. The numbers in the gates indicate mean fluorescence intensity of MHC class I molecules for GFP-negative and -positive populations.
(B) C1498 cells were transduced with either full-length CPXV203-HA (FL) or KTEL-deleted CPXV203-HA (DKTEL). Cells were metabolically labeled
for 10 min and chased for the indicated time periods. CPXV203 was immunoprecipitated from either the cell lysates (L) or the culture supernatants
(S) with anti-HA antibody.
(C) Band intensities of L and S fractions of the gel in (B) were quantified and plotted as percentage of total protein level (L+S) for each time point.CPXVD203 replicated normally in Vero cells as compared
to the wild-type CPXV (CPXV-WT) (data not shown).
MC57G cells infected with CPXVD203 demonstrated
less reduction of surface Kb than those infected with
CPXV-WT (Figure 7C). This was not due to a difference
in multiplicity of infection because both viruses infected
MC57G cells similarly, as measured by poxvirus hemag-
glutinin staining (Figure 7C). Deletion of the GFP cassette
from CPXVD203 by Cre recombinase did not affect the
phenotype of CPXVD203 (data not shown). These data
confirmed that CPXV203 plays a major, nonredundant
role in MHC class I downregulation by CPXV.
Interestingly, CPXVD203 still induced substantial down-
regulation of Kb on the cell surface (Figure 7C). Moreover,
Kb heavy chains in CPXVD203-infected cells were mostly
EndoHsensitive as inCPXV-WT-infected cells (Figure 7D).
These data indicated that, in addition to CPXV203, CPXV
encodes another gene(s) that can modulate MHC class I
expression by blocking intracellular transport.
DISCUSSION
Here, we characterized the downregulation of murine
MHCclass Imolecules byCPXV. The broad effect of CPXV
on the MHC class I levels of various cell types elevates the
importance of understanding this immune evasion mech-
anism, since CPXV is known to infect diverse cell types in-
cluding epithelial cells, fibroblasts, and macrophages
in vivo (Martinez et al., 2000). Furthermore, we demon-
strated that murine MHC class I downregulation by CPXV
shares similarities with the human system (Dasgupta et al.,
2007). In bothmurine and human cells infectedwith CPXV,Cell Host &downregulation of MHC class I occurs with similar kinetics
and is independent of the intermediate and late gene ex-
pression. The assembly ofMHC class Imolecules appears
to be normal in both CPXV-infected murine and human
cells, although we observed increased total levels of Kb,
which was not reported for the human MHC class I mole-
cules. It is not clear whether it is due to a difference in spe-
cies, cell lines, or multiplicity of infection. Importantly, we
found that CPXV inhibits the intracellular trafficking of mu-
rine MHC class I molecules, as it does to the human MHC
class I molecules (Dasgupta et al., 2007). These data
strongly suggest that CPXV uses a same set of genes
and mechanisms to modulate murine and human MHC
class I expression.
Our combined findings reported here demonstrate the
mechanism by which CPXV203 modulates MHC class I
expression. CPXV203 protein associates with MHC class
I heavy chain and b2m, but not with TAP, suggesting that
this association likely occurs after fully assembled MHC
class I molecules disassociate from TAP and other mem-
bers of the peptide-loading complex. It is also consistent
with the intracellular accumulation of peptide-loaded
MHC class I molecules. Given that CPXV203 is a lumenal
protein, it must be interacting with the ectodomain ofMHC
class I, although this interaction may not be direct, i.e., it
may involve other host proteins. Once associated, the
CPXV203/MHC class I complex is ER retained by the
KTEL sequence of CPXV203 presumably interacting with
KDEL receptor.
The specificity of CPXV203-mediated immune evasion
mechanism is particularly intriguing. The expression of
CPXV203 does not appear to have a ‘‘dominant-negative’’Microbe 2, 306–315, November 2007 ª2007 Elsevier Inc. 311
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MHC Class I Downregulation by Cowpox VirusFigure 7. Partial Rescue of MHC Class I Downregulation by the Deletion of CPXV203
(A) CPXVD203was generated by homologous recombination betweenCPXV-WT and the GFP cassette flanked by two 500 bp homologous arms. The
GFP cassette is composed of VACV I1L promoter (pI1L) followed by GFP coding sequence and two loxP sites. Gray-filled arrows represent coding
regions of indicated ORFs, and the direction of arrows indicates the direction of transcription.
(B) MC57G cells weremock infected (Mock) or infected with CPXV-WT (WT) or CPXVD203 (D203) at aMOI of 5. At 24 hr postinfection, cells were lysed
and the lysates were analyzed by immunoblotting using polyclonal antibody raised against a C-terminal peptide of CPXV203.
(C) MC57G cells were either mock infected (black) or infected with CPXV-WT (dashed blue) or CPXVD203 (solid red). At 24 hr postinfection, cells were
stained with antibodies to Kb or poxviral hemagglutinin. Gray-filled histograms represent isotype-control staining.
(D) Cell lysates were prepared fromMC57G cells that weremock infected (Mock) or infectedwith CPXV-WT (WT) or CPXVD203 (D203) at aMOI of 5 for
24 hr, and treated with Endo H where indicated. Western blot analysis was performed using an anti-Kb antibody. Protein bands corresponding to the
Endo H-resistant (r), -sensitive (s), or -digested (d) Kb heavy chain (HC) are indicated.effect by saturating the KDEL receptor and thus aborting
themolecular chaperones retained in the ER by thismech-
anism. Calreticulin has a KDEL motif and ERp57 has a
QEDL, and both of them are implicated in facilitating
MHC class I assembly in the ER. However, we did not find
a significant difference in the expression levels of these
chaperones in the presence or absence of CPXV203
(data not shown), and the assembly of MHC class I ap-
pears to be normal inCPXV203-transduced cells. Perhaps
the high cargo retrieval capacity of the KDEL receptor
(Pelham, 1996), and the lower efficiency of KTEL as a re-
tention signal compared to KDEL (Vennema et al., 1992),
can explain how CPXV203 retains MHC class I molecules
without affecting the retention of the ER chaperones con-
taining KDEL-like motifs. After all, a complete block of this
retention mechanism may not be in the virus’ best interest
because KDEL-bearing ER chaperones may facilitate the
folding of viral proteins. Taken together, our data strongly
suggest that CPXV203 exploits a physiological pathway of
ER retention without disrupting overall ER quality control.
CPXV203 is highly conserved among some of the ortho-
poxviruses, including other strains of CPXV, MPXV, cam-
elpox virus, and taterapox virus, but its orthologs are trun-
cated or absent in other orthopoxviruses (Figure S4). This
may be not surprising because there is no single common312 Cell Host & Microbe 2, 306–315, November 2007 ª2007 Elimmunomodulatory gene that can be found in all poxvi-
ruses (Seet et al., 2003). However, it is noteworthy that
OMCP, the recently discovered antagonist of NK cells, is
conserved only among CPXV and MPXV that also encode
CPXV203 or its ortholog (Campbell et al., 2007). Consider-
ing that OMCP may be capable of compensating for NK
cell activation caused by CPXV203-mediated MHC class
I downregulation, it is attractive to speculate that these
immunomodulatory genes might have coevolved to com-
plement each other.
We speculate that our study may help understand a vir-
ulence difference between MPXV strains. Human mon-
keypox cases as well as infection studies of cynomolgus
monkeys and ground squirrels demonstrated that West
AfricanMPXV isolates were less virulent than Congo basin
isolates (Breman et al., 1980; Chen et al., 2005; Foster
et al., 1972; Ladnyj et al., 1972; Sbrana et al., 2007).
Through genome comparison of several West African
and Congo basin MPXV isolates, five genomic regions
were identified that may explain the observed differences
in pathogenicity between these two clades (Chen et al.,
2005; Likos et al., 2005). Proteins encoded in these
regions include orthologs of previously demonstrated
poxvirus immunomodulatory proteins such as the com-
plement control protein and interleukin-1b receptorsevier Inc.
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contains the ortholog of CPXV203. Congo basin isolates
encode a full-length ortholog with the conserved C-termi-
nal KTEL motif, whereas West African isolates encode
a truncated form, containing only the N-terminal one-third
of the full-length protein. Our preliminary experiments
suggest that the full-length ortholog B10R of Congo basin
strain Zaire, but not the truncated form of West African
strain COP-58, can downregulate human MHC class I
molecules from the cell surface (data not shown). It is
tempting to speculate that the absence of a functional
CPXV203 ortholog, and thus the inefficient CTL evasion,
might contribute to the attenuated phenotype of West
African isolates compared to that of Congo basin isolates.
CPXV203 is also distantly related to M-T4 protein of
myxoma virus, a leporipoxvirus causing rabbit myxomato-
sis (Figure S4). M-T4 contains KDEL-like retention motif
RDEL and was shown to localize in the ER (Barry et al.,
1997). The phenotype of M-T4-deleted virus suggested
that M-T4 is a virulence factor and prevents apoptosis in
infected lymphocytes, but the C-terminal RDEL motif was
not required for these functions (Hnatiuk et al., 1999). In-
terestingly, myxoma virus was shown to downregulate
MHC class I on the cell surface by targeting MHC class I
molecules for degradation in late endosomes and/or lyso-
somes (Boshkov et al., 1992; Zuniga et al., 1999), and
myxoma virus leukemia-associated protein (MV-LAP) was
demonstrated to be responsible for MHC class I endocy-
tosis and degradation in myxoma virus-infected cells
(Guerin et al., 2002). Considering the similarity between
CPXV203 and M-T4, such as the presence of the KDEL-
like motif andmultiple conserved cysteines, it would be in-
teresting to test whether M-T4 also plays a role in myxoma
virus-mediated MHC class I downregulation. Vice versa,
whether CPXV203 has an M-T4 like antiapoptotic function
needs to be determined.
Even in the absence of CPXV203, CPXV blocks the traf-
ficking of most MHC class I molecules through the Golgi
complex, indicating it encodes as yet another gene(s)
that can retain MHC class I molecules in the pre-Golgi
compartments. Perhaps this is not surprising, since other
large DNA viruses contain multiple ORFs that target differ-
ent steps of MHC class I biosynthesis pathway. The MHC
class I retention mechanism(s) employed by this gene(s)
must be different from that of CPXV203 because
CPXV203 is the only CPXV BR gene containing a C-termi-
nal KDEL-like sequence. We are currently investigating
the identity of this CPXV gene(s). Although in vivo valida-
tion of the role that CPXV-inducedMHC class I downregu-
lation plays in CTL evasion and in virulence will have to
await the identification and deletion of all individual genes
that are involved, our work provides a stepping stone for
understanding CPXV pathogenesis.
EXPERIMENTAL PROCEDURES
Cell Lines and Virus
Cell lines MC57G, L929, C1498, Jurkat, 293T, Vero, and CV-1 were
obtained from American Type Culture Collection (ATCC, Manassas,Cell Host &VA) and cultured in recommended media. Bone marrow-derived mac-
rophages were generated by culturing single-cell suspension of bone
marrow from C57BL/6 or BALB/c mice in Dulbecco’s modified Eagle’s
medium (Sigma) supplementedwith 10% fetal calf serum and L929 cell
supernatant. B6/WT-3 (Lybarger et al., 2003) is an SV-40 transformed
C57BL/6 murine embryo fibroblast line. Cowpox virus strain Brighton
Red was obtained from ATCC and amplified in Vero cells. Viruses
were purified from the infected Vero cell lysates by centrifugation
through 36% sucrose solution. Titers of virus stocks were quantified
by plaque assays using CV-1 cells.
Flow Cytometry
The following monoclonal antibodies were used for flow cytometry;
AF6-88.5 for Kb, KH95 for Db, SF1-1.1 for Kd, 34-2-12 for Dd, C2 for
transferrin receptor, M1/70 for CD11b (all from BD Biosciences), W6/
32 (ATCC) for HLA-ABC, and IH831 (a gift of G. Karupiah, Australian
National University) for poxvirus hemagglutinin. For intracellular stain-
ing, cells were fixed and permeabilized with 4% (w/v) paraformalde-
hyde/0.1% (w/v) saponin prior to antibody staining. All flow cytometric
analyses were performed using a FACSCalibur (Becton Dickinson),
and the data were analyzed using FlowJo software (Tree Star).
Metabolic Labeling and Immunoprecipitation
Cells subject to metabolic labeling were incubated with PRO-MIX
L-[35S] in vitro cell-labeling mix (Amersham Biosciences) at 500 mCi/
ml for 10min. After the labeling medium was removed, cells were incu-
bated in the chasemediumwith excess unlabeledmethionine/cysteine
(5 mM each) for the indicated chase periods. Cells were washed, and
were lysed in 0.5%NP-40 (Sigma) in Tris-buffered saline (TBS) (10 mM
Tris [pH 7.6], 150 mM sodium chloride) with protease inhibitor cocktail
(Roche). Postnuclear lysates were precleared and incubated for 2 hr at
4C with protein A sepharose (PAS) (RepliGen) or protein G sepharose
(PGS) (Amersham Biosciences) that were preincubated with the
following mAbs: anti-Db 28-14-8 (ATCC), anti-Kb B8-24-3 (ATCC),
anti-transferrin receptor YTA74.4 (Serotec), or anti-HA 16B12 (Cova-
nce). After stringent washing, precipitated proteins were eluted from
PAS or PGS and subjected to SDS-PAGE. For the trafficking studies,
eluted proteins were treatedwith 10mU of Endoglycosidase H (Roche)
for 2 hr at 37C prior to SDS-PAGE. Protein band intensities were
quantified by ImageQuant TL (Amersham Biosciences).
Cloning of CPXV ORFs and Retroviral Transduction
Genomes of CPXV strain BR, VACV strain WR, and ECTV strain
Moscow were compared using Ortholog Comparisons function of
the PBRC website (http://www.poxvirus.org/). For the transduction
of murine cell lines, candidate ORFs including CPXV203 were cloned
from CPXV genomic DNA into a bicistronic retroviral expression vector
pMXsIG (T. Kitamura, University of Tokyo), which contains an internal
ribosomal entry site followed by a second cistron for GFP. Plat-E cells
(T. Kitamura, University of Tokyo) were transfected with individual con-
struct using FuGENE6 (Roche). The supernatants containing retrovi-
ruses were harvested at day 2 and used to transduce the target cells.
For the transduction of human cell lines, CPXV203was subcloned into
pHSPG vector (L. Su, University of North Carolina), which contains
pGK-driven GFP, and amphotropic phoenix cells (ATCC) were used
to produce retroviruses. Hexadimethrine bromide (Sigma) was also
added to the final concentration of 5–10 mg/ml in the viral supernatants
to facilitate infection.
Confocal Laser Scanning Microscopy
B6/WT-3 cells grown on glass coverslips were fixed with 2% (w/v)
paraformaldehyde and permeablized with 0.2% (w/v) saponin. To
block nonspecific binding of antibodies, all staining was performed
in the presence of 10% (v/v) goat serum. Cells were stained with
mouse anti-HA 16B12, rabbit anti-calnexin (Sigma), or rabbit anti-
giantin, followed by Alexa Fluor 633-conjugated goat anti-mouse IgG
and Alexa Fluor 568-conjugated goat anti-rabbit IgG (MolecularMicrobe 2, 306–315, November 2007 ª2007 Elsevier Inc. 313
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MHC Class I Downregulation by Cowpox VirusProbes). Stained cells were analyzed with laser scanning confocal
microscope LSM510 (Zeiss).
Coimmunoprecipitation
Cells were lysed in TBS buffer containing 1% digitonin (Wako) and 20
mM iodoacetamide (Sigma). After preclearing over PGS, postnuclear
lysates were incubated with anti-HA 16B12 or mouse IgG1 isotype-
control 9E10 (ATCC) bound PGS for 2 hr at 4C. Proteins were eluted
fromPGSpellet by boiling in the nonreducing sample buffer, separated
by SDS-PAGE, and transferred to PVDFmembranes (Millipore). Immu-
noblotting was performed using rabbit anti-Kb, rabbit anti-b2m, rabbit
anti-TAP (Lybarger et al., 2003), and rabbit anti-HA (Covance),
followed by horseradish peroxidase (HRP)-conjugated goat anti-rabbit
IgG (Amersham Biosciences).
Generation of CPXV203-Deleted Virus
We followed a previously described protocol (Earl et al., 1998) with
modifications. Genomic segments (500 bp long) flanking the
CPXV203 coding region were amplified and cloned into pBluscriptII
KS (Stratagene). Between the flanking regionswere inserted a cassette
that expresses GFP under the VACV I1L promoter (TATTTAAAAG
TTGTTTGGTGAACTTAA) (Liu et al., 2004) and two loxP sequences
(ATAACTTCGTATAGCATACATTATACGAAGTTAT). The plasmid was
transfected into CPXV-infected CV-1 cells using FuGENE6.
CPXV203-deleted virus (CPXVD203) was purified from green fluores-
cent plaques by five rounds of plaque purification. For the deletion of
the GFP cassette, CV-1 cells transiently expressing Cre recombinase
were infected with CPXVD203, and the GFP-free CPXVD203 was pu-
rified from nonfluorescent plaques by five rounds of plaque purifica-
tion. Deletion of CPXV203 was confirmed by western blot analysis
using anti-CPXV203 antibody, which was raised in chicken by immu-
nizing with C-terminal peptide CTNTKFDRSVYKTHMQKSKILHVKTEL
(AVES) and HRP-conjugated goat anti-chicken IgY (AVES).
Supplemental Data
The Supplemental Data include four supplemental figures and can be
found with this article online at http://www.cellhostandmicrobe.com/
cgi/content/full/2/5/306/DC1/.
ACKNOWLEDGMENTS
This work was supported by the Midwest Regional Center of Excel-
lence for Biodefense (NIH U54-AI057160), and the Barnes-Jewish
Hospital Foundation. W.M.Y. is an investigator of the Howard Hughes
Medical Institute. T.H.H. is supported by NIH grant AI019687.
Received: July 18, 2007
Revised: August 13, 2007
Accepted: September 7, 2007
Published: November 14, 2007
REFERENCES
Andres, D.A., Dickerson, I.M., and Dixon, J.E. (1990). Variants of the
carboxyl-terminal KDEL sequence direct intracellular retention. J.
Biol. Chem. 265, 5952–5955.
Andres, D.A., Rhodes, J.D., Meisel, R.L., and Dixon, J.E. (1991). Char-
acterization of the carboxyl-terminal sequences responsible for pro-
tein retention in the endoplasmic reticulum. J. Biol. Chem. 266,
14277–14282.
Barry, M., Hnatiuk, S., Mossman, K., Lee, S.F., Boshkov, L., and
McFadden, G. (1997). The myxoma virus M-T4 gene encodes a novel
RDEL-containing protein that is retained within the endoplasmic retic-
ulum and is important for the productive infection of lymphocytes.
Virology 239, 360–377.
Boshkov, L.K., Macen, J.L., and McFadden, G. (1992). Virus-induced
loss of class I MHC antigens from the surface of cells infected with314 Cell Host & Microbe 2, 306–315, November 2007 ª2007 Elsmyxoma virus and malignant rabbit fibroma virus. J. Immunol. 148,
881–887.
Breman, J.G., Kalisa, R., Steniowski, M.V., Zanotto, E., Gromyko, A.I.,
and Arita, I. (1980). Human monkeypox, 1970–79. Bull. World Health
Organ. 58, 165–182.
Campbell, J.A., Trossman, D.S., Yokoyama, W.M., and Carayanno-
poulos, L.N. (2007). Zoonotic orthopoxviruses encode a high-affinity
antagonist of NKG2D. J. Exp. Med. 204, 1311–1317.
Chantrey, J., Meyer, H., Baxby, D., Begon, M., Bown, K.J., Hazel,
S.M., Jones, T., Montgomery, W.I., and Bennett, M. (1999). Cowpox:
Reservoir hosts and geographic range. Epidemiol. Infect. 122, 455–
460.
Chen, N., Li, G., Liszewski, M.K., Atkinson, J.P., Jahrling, P.B., Feng,
Z., Schriewer, J., Buck, C., Wang, C., Lefkowitz, E.J., et al. (2005).
Virulence differences between monkeypox virus isolates from West
Africa and the Congo basin. Virology 340, 46–63.
Dasgupta, A., Hammarlund, E., Slifka, M.K., and Fruh, K. (2007). Cow-
pox virus evades CTL recognition and inhibits the intracellular trans-
port of MHC class I molecules. J. Immunol. 178, 1654–1661.
Earl, P.L., Moss, B., Wyatt, L.S., and Carroll, M.W. (1998). Generation
of recombinant vaccinia viruses. In Current Protocols in Molecular
Biology (Hoboken, NJ: John Wiley & Sons), pp. 16.17.11–16.17.19.
Fenner, F., Henderson, D.A., Arita, I., Jezek, Z., and Ladnyi, I.D. (1988).
Smallpox and Its Eradication (Geneva: World Health Organization).
Foster, S.O., Brink, E.W., Hutchins, D.L., Pifer, J.M., Lourie, B., Moser,
C.R., Cummings, E.C., Kuteyi, O.E., Eke, R.E., Titus, J.B., et al. (1972).
Human monkeypox. Bull. World Health Organ. 46, 569–576.
Guerin, J.L., Gelfi, J., Boullier, S., Delverdier, M., Bellanger, F.A.,
Bertagnoli, S., Drexler, I., Sutter, G., and Messud-Petit, F. (2002).
Myxoma virus leukemia-associated protein is responsible for major
histocompatibility complex class I and Fas-CD95 down-regulation
and defines scrapins, a new group of surface cellular receptor abduc-
tor proteins. J. Virol. 76, 2912–2923.
Guidotti, L.G., and Chisari, F.V. (1996). To kill or to cure: Options in host
defense against viral infection. Curr. Opin. Immunol. 8, 478–483.
Hnatiuk, S., Barry, M., Zeng, W., Liu, L., Lucas, A., Percy, D., and
McFadden, G. (1999). Role of the C-terminal RDEL motif of the myx-
oma virus M-T4 protein in terms of apoptosis regulation and viral path-
ogenesis. Virology 263, 290–306.
Jezek, Z., Szczeniowski, M., Paluku, K.M., and Mutombo, M. (1987).
Human monkeypox: Clinical features of 282 patients. J. Infect. Dis.
156, 293–298.
Ladnyj, I.D., Ziegler, P., and Kima, E. (1972). A human infection caused
by monkeypox virus in Basankusu Territory, Democratic Republic of
the Congo. Bull. World Health Organ. 46, 593–597.
Lewis-Jones, S. (2004). Zoonotic poxvirus infections in humans. Curr.
Opin. Infect. Dis. 17, 81–89.
Likos, A.M., Sammons, S.A., Olson, V.A., Frace, A.M., Li, Y., Olsen-
Rasmussen, M., Davidson, W., Galloway, R., Khristova, M.L., Rey-
nolds, M.G., et al. (2005). A tale of two clades: Monkeypox viruses.
J. Gen. Virol. 86, 2661–2672.
Liu, X., Kremer, M., and Broyles, S.S. (2004). A natural vaccinia virus
promoter with exceptional capacity to direct protein synthesis. J. Virol.
Methods 122, 141–145.
Lybarger, L., Wang, X., Harris, M.R., Virgin, H.W., IV, and Hansen, T.H.
(2003). Virus subversion of the MHC class I peptide-loading complex.
Immunity 18, 121–130.
Martinez, M.J., Bray, M.P., and Huggins, J.W. (2000). A mouse model
of aerosol-transmitted orthopoxviral disease: Morphology of experi-
mental aerosol-transmitted orthopoxviral disease in a cowpox virus-
BALB/c mouse system. Arch. Pathol. Lab. Med. 124, 362–377.
Meyer, H., Neubauer, H., and Pfeffer, M. (2002). Amplification of ‘var-
iola virus-specific’ sequences in German cowpox virus isolates. J. Vet.
Med. B Infect. Dis. Vet. Public Health 49, 17–19.evier Inc.
Cell Host & Microbe
MHC Class I Downregulation by Cowpox VirusPamer, E., and Cresswell, P. (1998). Mechanisms of MHC class I-re-
stricted antigen processing. Annu. Rev. Immunol. 16, 323–358.
Pelham, H.R. (1996). The dynamic organisation of the secretory path-
way. Cell Struct. Funct. 21, 413–419.
Reed, K.D., Melski, J.W., Graham, M.B., Regnery, R.L., Sotir, M.J.,
Wegner, M.V., Kazmierczak, J.J., Stratman, E.J., Li, Y., Fairley, J.A.,
et al. (2004). The detection of monkeypox in humans in the Western
Hemisphere. N. Engl. J. Med. 350, 342–350.
Sasada, T., Ghendler, Y., Neveu, J.M., Lane, W.S., and Reinherz, E.L.
(2001). A naturally processed mitochondrial self-peptide in complex
with thymic MHC molecules functions as a selecting ligand for a vi-
ral-specific T cell receptor. J. Exp. Med. 194, 883–892.
Sbrana, E., Xiao, S.Y., Newman, P.C., and Tesh, R.B. (2007). Compar-
ative pathology of North American and central African strains of mon-
keypox virus in a ground squirrel model of the disease. Am. J. Trop.
Med. Hyg. 76, 155–164.
Seet, B.T., Johnston, J.B., Brunetti, C.R., Barrett, J.W., Everett, H.,
Cameron, C., Sypula, J., Nazarian, S.H., Lucas, A., and McFadden,
G. (2003). Poxviruses and immune evasion. Annu. Rev. Immunol. 21,
377–423.Cell Host &Shchelkunov, S., Totmenin, A., and Kolosova, I. (2002). Species-spe-
cific differences in organization of orthopoxvirus kelch-like proteins.
Virus Genes 24, 157–162.
Smith, G.L., andMcFadden, G. (2002). Smallpox: Anything to declare?
Nat. Rev. Immunol. 2, 521–527.
Tortorella, D., Gewurz, B.E., Furman, M.H., Schust, D.J., and Ploegh,
H.L. (2000). Viral subversion of the immune system. Annu. Rev. Immu-
nol. 18, 861–926.
Townsend, A., Ohlen, C., Bastin, J., Ljunggren, H.G., Foster, L., and
Karre, K. (1989). Association of class I major histocompatibility heavy
and light chains induced by viral peptides. Nature 340, 443–448.
Vennema, H., Heijnen, L., Rottier, P.J., Horzinek, M.C., and Spaan,
W.J. (1992). A novel glycoprotein of feline infectious peritonitis corona-
virus contains a KDEL-like endoplasmic reticulum retention signal. J.
Virol. 66, 4951–4956.
Zuniga, M.C., Wang, H., Barry, M., and McFadden, G. (1999). Endoso-
mal/lysosomal retention and degradation of major histocompatibility
complex class I molecules is induced by myxoma virus. Virology
261, 180–192.Microbe 2, 306–315, November 2007 ª2007 Elsevier Inc. 315
